FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

386775009: Product containing neostigmine in parenteral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3710995012 Product containing neostigmine in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3710996013 Neostigmine-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


7 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing neostigmine in parenteral dose form (medicinal product form) est un(e) (attribut) Product containing neostigmine (medicinal product) true Inferred relationship Some
Product containing neostigmine in parenteral dose form (medicinal product form) a pour principe actif (attribut) Neostigmine (substance) true Inferred relationship Some 1
Product containing neostigmine in parenteral dose form (medicinal product form) a une forme pharmaceutique (attribut) Injection false Inferred relationship Some
Product containing neostigmine in parenteral dose form (medicinal product form) a une forme pharmaceutique (attribut) forme pharmaceutique pour usage parentéral (forme pharmaceutique) true Inferred relationship Some
Product containing neostigmine in parenteral dose form (medicinal product form) est un(e) (attribut) Product manufactured as parenteral dose form (product) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Glycopyrronium- and neostigmine-containing product in parenteral dose form est un(e) (attribut) True Product containing neostigmine in parenteral dose form (medicinal product form) Inferred relationship Some
Product containing only neostigmine in parenteral dose form (medicinal product form) est un(e) (attribut) True Product containing neostigmine in parenteral dose form (medicinal product form) Inferred relationship Some
Neostigmine methylsulfate 2.5mg/1mL injection (product) est un(e) (attribut) False Product containing neostigmine in parenteral dose form (medicinal product form) Inferred relationship Some
Prostigmin 2.5mg/1mL injection (product) est un(e) (attribut) False Product containing neostigmine in parenteral dose form (medicinal product form) Inferred relationship Some
Neostigmine 2.5mg/glycopyrronium 500mcg injection solution 1mL ampule (product) est un(e) (attribut) False Product containing neostigmine in parenteral dose form (medicinal product form) Inferred relationship Some
Neostigmine methylsulfate 0.5mg/mL injection (product) est un(e) (attribut) False Product containing neostigmine in parenteral dose form (medicinal product form) Inferred relationship Some
Neostigmine methylsulfate 0.25mg/mL injection (product) est un(e) (attribut) False Product containing neostigmine in parenteral dose form (medicinal product form) Inferred relationship Some
Neostigmine methylsulfate 1mg/mL injection (product) est un(e) (attribut) False Product containing neostigmine in parenteral dose form (medicinal product form) Inferred relationship Some
Prostigmin 2.5mg/1mL injection (product) est un(e) (attribut) False Product containing neostigmine in parenteral dose form (medicinal product form) Inferred relationship Some
Neostigmine+glycopyrronium (product) est un(e) (attribut) False Product containing neostigmine in parenteral dose form (medicinal product form) Inferred relationship Some
Neostigmine 2.5mg/glycopyrronium 500mcg injection solution 1mL ampule (product) est un(e) (attribut) False Product containing neostigmine in parenteral dose form (medicinal product form) Inferred relationship Some
Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection ampule est un(e) (attribut) False Product containing neostigmine in parenteral dose form (medicinal product form) Inferred relationship Some
Product containing precisely neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) est un(e) (attribut) False Product containing neostigmine in parenteral dose form (medicinal product form) Inferred relationship Some

This concept is not in any reference sets

Back to Start